TipHub

12.8

-0.26 -1.99%

30 Jul 2026

BSE Listed

ESM · ESM 1
What does ESM · ESM 1 mean?
BSE · Enhanced Surveillance Measure (ESM 1)ESM is the micro/small-cap ramp brake: it fires when a sub-₹1000cr stock's price variation is extreme versus its peer universe, or it's loss-making with a stretched valuation. Practical meaning: intraday speculation is shut off (Trade-for-Trade — every purchase must be taken to delivery), margins go to 100%, and at Stage II price discovery moves to periodic call auctions inside a 2% band.Criteria: Micro / small-cap companies (main-board market-cap below ₹500 cr) shortlisted on objective price parameters — high-low price variation, close-to-close price variation and standard deviation. Stage I = 100% margin + a ≤5% price band + Trade-for-Trade; Stage II = a 2% price band + periodic call auction.Exchange notice · 2026-06-16

Deccan Health Care Limited (542248)

Volume: 13,925Avg Vol 1W: 8,339Avg Vol 1M: 6,29952W Range:6.6521.8
Key Ratios
Checked 6h ago
Market Cap₹32 Cr
Current Price₹12.8
Previous Close₹13.06
High / Low (52w)₹21.8 / ₹6.65
Volume13,925
Avg Vol (1W)8,339
Avg Vol (1M)6,299
Stock P/E12.67
Book Value₹44.55
Dividend Yield0%
ROE225.61%
ROA166.54%
Revenue (TTM)
Revenue Growth
Profit Margin302.77%
Total Debt
Shares Outstanding2 Cr
Face Value
EPS (TTM)₹1.01
P/B0.29
Debt / Equity0.01
50 DMA₹12.96
200 DMA₹13.64
Day change-1.99%
SurveillanceESM · ESM 1
Price Chart
12.8 39.34% · 1Y
2472.9L
2025-07-30
2026-07-30

20-day avg volume: 6K shares

Pros
  • Healthy return on equity of 225.6%.
  • Company is almost debt-free.
  • Stock trades below its book value.
Cons
  • Revenue fell 12% YoY.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹15 Cr₹19 Cr₹20 Cr₹21 Cr₹22 Cr₹21 Cr₹17 Cr₹21 Cr
EBITDA₹1 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹1 Cr₹1 Cr
Net Profit₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹1 Cr₹0 Cr
EPS
Profit & Loss (Annual)
MetricSept 2024Dec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹19 Cr₹20 Cr₹21 Cr₹75 Cr₹21 Cr₹24 Cr₹23 Cr₹20 Cr
EBITDA₹1 Cr₹0 Cr₹0 Cr₹2 Cr₹0 Cr₹1 Cr₹1 Cr₹0 Cr
Net Profit₹1 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹1 Cr₹1 Cr₹0 Cr
EPS0.45
Balance Sheet
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹92 Cr₹91 Cr₹97 Cr₹108 Cr₹125 Cr
Total Liabilities₹16 Cr₹14 Cr₹15 Cr₹11 Cr₹19 Cr
Equity₹77 Cr₹77 Cr₹82 Cr₹97 Cr₹106 Cr
Total Debt
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹0 Cr₹0 Cr₹-7 Cr₹-12 Cr₹-6 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Financing₹0 Cr₹0 Cr₹5 Cr₹14 Cr₹8 Cr
Free Cash Flow₹0 Cr₹0 Cr₹-7 Cr₹-12 Cr₹-6 Cr
Shareholding
Promoter 19.46% Institutions 5.68% Public 74.86%
Efficiency & Working Capital
ROCE3.2%
Interest Coverage24.3
Dividend Payout
Debtor Days61 d
Inventory Days207 d
Payable Days44 d
Cash Conversion Cycle224 d
Working Capital Days268 d
Shareholding Details

As of 2026-06-30

Promoter19.5%
FII0%
DII5.7%
Institutions5.7%
Public74.9%
Promoter Pledge0%
No. of Shareholders4,084
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Oct 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters16.1%16.1%16.1%15.7%19%18.3%19.5%18.4%18.4%18.4%19.5%19.5%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%6.5%6.5%6.3%6.1%5.9%5.7%5.4%5.4%5.4%5.7%5.7%
Public83.9%77.4%77.4%78%75%75.9%74.9%76.2%76.2%76.2%74.9%74.9%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders2,0412,7373,0023,1543,1543,4163,6143,6673,7433,9264,0044,084
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Minto Purshotam GuptaShareholding of Promoter and Promoter Group14.5%33,86,592
Focal Ventures Private LimitedPublic Shareholding9.7%22,70,896
Kolla Umanja Venkata Satya Siva SrihariPublic Shareholding6.7%15,58,238
Venture Gurukool Investment TrustPublic Shareholding5.7%13,29,750
Meenakshi GuptaShareholding of Promoter and Promoter Group5%11,72,146
Patni Rakesh .Public Shareholding4.7%11,07,953
Vikram Sharad ShethPublic Shareholding3%7,08,310
Kolla SangeethaPublic Shareholding2.6%6,08,199
Hiral Saurabh ShahPublic Shareholding1.7%4,00,000
Prasad Rajnikant ShethPublic Shareholding1.5%3,55,200
Surinder KaurPublic Shareholding1.3%3,00,000
Punit Vikram ShethPublic Shareholding1.2%2,68,710
Board of Directors
NameDesignationYear
Minto GuptaChairman & Managing Director2025
Meenakshi GuptaNon-Exec & Non-Independent Dir2025
Ravi Ramprasad.Non-Exec & Non-Independent Dir2025
UMANJA VENKATA SATYA SIVA SRIHARI KOLLANon-Exec & Non-Independent Dir2025
Ruchi KhattarIndependent Non Exe. Director2025
Kandlakunta SamhithaIndependent Non Exe. Director2025
Viraj Shaileshkumar ShahIndependent Non Exe. Director2025
Bhavika SanghaniIndependent Non Exe. Director2025
Ronak DarjiCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Nutraceutical Products₹38 Cr95.4%
Pharmaceutical Products₹2 Cr4.6%
Segments — Geography
RegionRevenueShare
Export Sales₹0 Cr0.3%
Domestic Sales₹60 Cr99.7%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10262323
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025150108
2025110104
2025040004
Substantial Acquisitions (SAST)

1 disclosure(s)

Conv. of Warrants12/11/2024 · 8,53,334
Company Information
Incorporated1996
ChairmanMinto Gupta
AuditorKeyur Shah & Associates
Investor Email[email protected]
🌐 www.deccanhealthcare.co.in

📍 247 2nd Flr Dwarakapuri Colony, Punjagutta, Hyderabad, Telangana, 500082

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search